2004
DOI: 10.1128/jb.186.4.1200-1204.2004
|View full text |Cite
|
Sign up to set email alerts
|

Benzoate Decreases the Binding of cis , cis -Muconate to the BenM Regulator despite the Synergistic Effect of Both Compounds on Transcriptional Activation

Abstract: Fluorescence emission spectroscopy was used to investigate interactions between two effectors and BenM, a transcriptional regulator of benzoate catabolism. BenM had a higher affinity for cis,cis-muconate than for benzoate as the sole effector. However, the presence of benzoate increased the apparent dissociation constant (reduced the affinity) of the protein for cis,cis-muconate. Similar results were obtained with truncated BenM lacking the DNA-binding domain. High-level transcriptional activation may require … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
26
0

Year Published

2004
2004
2017
2017

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 22 publications
(28 citation statements)
references
References 21 publications
2
26
0
Order By: Relevance
“…In the presence of inducer, the hypersensitive band at Ϫ42 disappeared and occupation of the ABS shifted from Ϫ37 to Ϫ41 (141), suggesting that the bending angle is relaxed on interaction with the effector. Conformational changes on effector binding could be detected for benzoate and cis,cis-muconate binding to BenM (31). Measurements of the bending angle of the clcA promoter in the absence (71°) and in the presence (55°) of effector corroborate this idea of bending relaxation (140).…”
Section: Mechanisms Of Activationsupporting
confidence: 63%
See 2 more Smart Citations
“…In the presence of inducer, the hypersensitive band at Ϫ42 disappeared and occupation of the ABS shifted from Ϫ37 to Ϫ41 (141), suggesting that the bending angle is relaxed on interaction with the effector. Conformational changes on effector binding could be detected for benzoate and cis,cis-muconate binding to BenM (31). Measurements of the bending angle of the clcA promoter in the absence (71°) and in the presence (55°) of effector corroborate this idea of bending relaxation (140).…”
Section: Mechanisms Of Activationsupporting
confidence: 63%
“…For example, fumarate reversibly inhibits the formation of the clcA transcript in in vitro transcription assays in the presence of purified ClcR and 2-chloro-cis,cis-muconate (138). The presence of cis,cis-muconate decreases the affinity of the BenM protein for benzoate (31). All LTTRs repress their own expression, and both autorepression and activation of the catabolic operon promoter are exerted from the same binding site, which is called the regulator or repressor binding site (RBS) (20,216,227).…”
Section: Lysr Family Of Transcriptional Regulators Catabolic Operons mentioning
confidence: 99%
See 1 more Smart Citation
“…6B), allowing us to carry out a fluorescence titration assay. Titration of the protein with increasing amounts of benzoyl-CoA yields a binding isotherm with a dissociation constant (K d ) of 157 Ϯ 58 M, a value that is within the range of that obtained with other transcriptional regulators that control aromatic degradation pathways (54). This analysis assumes a single binding site for benzoyl-CoA that should be located at the C-terminal domain of BzdR, as deduced from the structural model of the protein (7).…”
Section: Conformational Changes In Bzdr Upon Benzoyl-coa Binding-mentioning
confidence: 99%
“…This finding expands our current view of the PaaX regulon to include the catabolism of toxic aromatic compounds, such as styrene, and places the PaaX protein at the center of an interesting case of an integrated regulatory strategy for the catabolism of aromatic compounds (reviewed by Shingler [34]), namely, a mechanism in which transcriptional control of the expression of the catabolic genes integrates responses to both a substrate (styrene through StyR/StyS) and a pathway intermediate (PA-CoA through PaaX). Conceptually, this regulatory scheme is reminiscent of that reported for the sub-strate benzoate and intermediate cis-muconate in control of benzoate catabolism through the ␤-ketoadipate pathway (7,8).…”
mentioning
confidence: 99%